Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Molecular Medicine (Berlin, Germany)|December 14, 2004
Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune diseaseWilliam F Pendergraft, Barrak M Pressler, J Charles Jennette, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated VasculitisFrank B Cortazar, William F Pendergraft, Julia Wenger, et al.
American Journal of Nephrology|April 27, 2017
Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North CarolinaMichelle M O'Shaughnessy, Meghan A Jobson, Katy Sims, et al.
BMC Nephrology|February 2, 2017
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case seriesFrank B Cortazar, David E Leaf, Charles T Owens, et al.
Autoimmunity|October 30, 2007
A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 proteinLila Farrag, William F Pendergraft, J J Yang, et al.
The American Journal of Pathology|June 27, 2007
Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin systemJoshua M Astern, William F Pendergraft, Ronald J Falk, et al.
Kidney International Reports|May 5, 2018
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA VasculitisFrank B Cortazar, Saif A Muhsin, William F Pendergraft, et al.
Nature Medicine|December 9, 2003
Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3William F Pendergraft, Gloria A Preston, Ruchir R Shah, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitisWilliam F Pendergraft, Frank B Cortazar, Julia Wenger, et al.
American Journal of Nephrology|March 20, 2017
The Evolving Role of Rituximab in Adult Minimal Change GlomerulopathyLandon C Brown, Meghan A Jobson, Fernanda Payan Schober, et al.
Pageof 5